BioImpact Capital

BioImpact Capital is a Boston-based venture capital firm investing across biotechnology, life sciences, pharmaceuticals and oncology, with an impact-oriented focus on companies that can transform patient outcomes. The firm manages over $3 billion in AUM across early-stage venture, private/public impact and public equities strategies, and invests longitudinally from seed through follow-on financings, including later-stage venture rounds. It targets opportunities in the United States and APAC.